Rapidx
At-home Rapid Diagnostic Tests
Company Overview
Snapshot
Founded in January 2008 by Idan Tamir, Rapidx operated with 1–10 employees. The company secured $1M in total capital across two funding rounds from two investors.
Business overview
Rapidx developed self-administered rapid blood diagnostic tests designed for discreet home use across various health conditions. The company's core technology integrated the lancet, blood collection, and rapid diagnostic test into a single, affordable, and disposable device, aiming to address the pain and contamination risks associated with traditional blood extraction. Rapidx served the growing point-of-care (POC) and homecare markets, operating within the Health Tech & Life Sciences sector, specifically focusing on Medical Devices and Diagnostics Devices.
Strategic signal
Rapidx ceased operations in January 2023, indicating a significant strategic shift and the conclusion of its business activities. This event signals to investors and innovation teams that the company is no longer active in the market, marking the end of its development and commercialization efforts in rapid diagnostic testing.
Log in to access full profile ›Company Intelligence Q&A
- What is Rapidx's primary focus?
- Rapidx focused on developing self-administered rapid blood diagnostic tests for at-home use, aiming to provide convenient and less painful diagnostic solutions for various health conditions.
- When was Rapidx founded?
- Rapidx was founded in January 2008.
- What was a key technological innovation by Rapidx?
- Rapidx integrated the lancet, blood collection, and rapid diagnostic test into one disposable device to simplify the process and reduce pain and contamination risks associated with blood extraction.
- What was the outcome of Rapidx's clinical trial?
- Rapidx completed a clinical trial at Tel Aviv Medical Center with 30 volunteers, demonstrating faster blood extraction and less pain compared to the gold-standard technique. This led to the registration of an FDA 510(k) patent on its novel blood extraction component.
- What is the current operational status of Rapidx?
- Rapidx ceased to operate in January 2023.